<TABLE BORDER>
<tr><td>Model</td><td>Freq.</td></tr>
<tr><td>2124.Zyxin + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.085</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 2124.Zyxin</td><td><div align=right>0.015</div></td></tr>
<tr><td>1042.CCND3 Cyclin D3 + 2124.Zyxin</td><td><div align=right>0.015</div></td></tr>
<tr><td>2124.Zyxin + 2670.ELA2 Elastatse 2, neutrophil</td><td><div align=right>0.015</div></td></tr>
<tr><td>2124.Zyxin + 523.SPTAN1 Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)</td><td><div align=right>0.015</div></td></tr>
<tr><td>2124.Zyxin + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage)</td><td><div align=right>0.015</div></td></tr>
<tr><td>2386.TOP2B Topoisomerase (DNA) II beta (180kD) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.015</div></td></tr>
<tr><td>829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.015</div></td></tr>
<tr><td>894.PPBP Connective tissue activation peptide III + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.015</div></td></tr>
<tr><td>1448.Leukotriene C4 synthase (LTC4S) gene + 2124.Zyxin</td><td><div align=right>0.010</div></td></tr>
<tr><td>1448.Leukotriene C4 synthase (LTC4S) gene + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.010</div></td></tr>
<tr><td>1524.Putative enterocyte differentiation promoting factor mRNA, partial cds + 2124.Zyxin</td><td><div align=right>0.010</div></td></tr>
<tr><td>1556.Lysophospholipase homolog (HU-K5) mRNA + 2124.Zyxin</td><td><div align=right>0.010</div></td></tr>
<tr><td>1834.VIL2 Villin 2 (ezrin) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.010</div></td></tr>
<tr><td>1907.GRN Granulin + 2124.Zyxin</td><td><div align=right>0.010</div></td></tr>
<tr><td>2124.Zyxin + 2386.TOP2B Topoisomerase (DNA) II beta (180kD)</td><td><div align=right>0.010</div></td></tr>
<tr><td>2124.Zyxin + 2386.TOP2B Topoisomerase (DNA) II beta (180kD) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.010</div></td></tr>
<tr><td>2124.Zyxin + 2600.APLP2 Amyloid beta (A4) precursor-like protein 2</td><td><div align=right>0.010</div></td></tr>
<tr><td>2124.Zyxin + 2600.APLP2 Amyloid beta (A4) precursor-like protein 2 + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.010</div></td></tr>
<tr><td>2124.Zyxin + 738.Terminal transferase mRNA</td><td><div align=right>0.010</div></td></tr>
<tr><td>2124.Zyxin + 786.Neuromedin B mRNA</td><td><div align=right>0.010</div></td></tr>
<tr><td>2124.Zyxin + 808.CD33 CD33 antigen (differentiation antigen)</td><td><div align=right>0.010</div></td></tr>
<tr><td>2386.TOP2B Topoisomerase (DNA) II beta (180kD) + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage)</td><td><div align=right>0.010</div></td></tr>
<tr><td>2600.APLP2 Amyloid beta (A4) precursor-like protein 2 + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.010</div></td></tr>
<tr><td>2939.TCF3 Transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.010</div></td></tr>
<tr><td>523.SPTAN1 Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.010</div></td></tr>
<tr><td>766.LYN V-yes-1 Yamaguchi sarcoma viral related oncogene homolog + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.010</div></td></tr>
<tr><td>1006.TCF12 Transcription factor 12 (HTF4, helix-loop-helix transcription factors 4) + 2670.ELA2 Elastatse 2, neutrophil</td><td><div align=right>0.005</div></td></tr>
<tr><td>1009.DF D component of complement (adipsin) + 2489.C-myb gene extracted from Human (c-myb) gene, complete primary cds, and five complete alternatively spliced cds</td><td><div align=right>0.005</div></td></tr>
<tr><td>1009.DF D component of complement (adipsin) + 766.LYN V-yes-1 Yamaguchi sarcoma viral related oncogene homolog + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 1069.Azurocidin gene + 1995.RETINOBLASTOMA BINDING PROTEIN P48 + 2289.MCM3 Minichromosome maintenance deficient (S. cerevisiae) 3 + 738.Terminal transferase mRNA + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage)</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 1995.RETINOBLASTOMA BINDING PROTEIN P48 + 2124.Zyxin + 283.KIAA0181 gene, partial cds + 2939.TCF3 Transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 2124.Zyxin + 3046.Transcriptional activator hSNF2b</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 2172.Nucleoside-diphosphate kinase</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 2438.CALM1 Calmodulin 1 (phosphorylase kinase, delta)</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 2499.Epican, Alt. Splice 11</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 2600.APLP2 Amyloid beta (A4) precursor-like protein 2</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 2664.INTERLEUKIN-8 PRECURSOR</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 2801.DHPS Deoxyhypusine synthase</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 746.ADA Adenosine deaminase + 894.PPBP Connective tissue activation peptide III</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 838.Translational initiation factor 2 beta subunit (elF-2-beta) mRNA + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 849.Oncoprotein 18 (Op18) gene</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 894.PPBP Connective tissue activation peptide III</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1037.ACADM Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain + 937.CTSD Cathepsin D (lysosomal aspartyl protease)</td><td><div align=right>0.005</div></td></tr>
<tr><td>1042.CCND3 Cyclin D3 + 2600.APLP2 Amyloid beta (A4) precursor-like protein 2</td><td><div align=right>0.005</div></td></tr>
<tr><td>1042.CCND3 Cyclin D3 + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1069.Azurocidin gene + 378.CYSTATIN A</td><td><div align=right>0.005</div></td></tr>
<tr><td>108.ADM Adrenomedullin + 1391.HOXA9 Homeo box A9 + 2870.HOX 2.2 gene extracted from Human Hox2.2 gene for a homeobox protein</td><td><div align=right>0.005</div></td></tr>
<tr><td>108.ADM Adrenomedullin + 140.NADPH-flavin reductase</td><td><div align=right>0.005</div></td></tr>
<tr><td>108.ADM Adrenomedullin + 2002.T-COMPLEX PROTEIN 1, GAMMA SUBUNIT</td><td><div align=right>0.005</div></td></tr>
<tr><td>1101.CDC10 Cell division cycle 10 (homologous to CDC10 of S. cerevisiae + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1413.GLUTATHIONE S-TRANSFERASE, MICROSOMAL + 1754.Catalase (EC 1.11.1.6) 5'flank and exon 1 mapping to chromosome 11, band p13 (and joined CDS) + 178.RANBP1 RAN binding protein 1 + 1977.CHRNA7 Cholinergic receptor, nicotinic, alpha polypeptide 7 + 2124.Zyxin + 894.PPBP Connective tissue activation peptide III + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1413.GLUTATHIONE S-TRANSFERASE, MICROSOMAL + 2124.Zyxin</td><td><div align=right>0.005</div></td></tr>
<tr><td>1413.GLUTATHIONE S-TRANSFERASE, MICROSOMAL + 2124.Zyxin + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1413.GLUTATHIONE S-TRANSFERASE, MICROSOMAL + 2600.APLP2 Amyloid beta (A4) precursor-like protein 2</td><td><div align=right>0.005</div></td></tr>
<tr><td>1413.GLUTATHIONE S-TRANSFERASE, MICROSOMAL + 808.CD33 CD33 antigen (differentiation antigen) + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage)</td><td><div align=right>0.005</div></td></tr>
<tr><td>1417.Phosphotyrosine independent ligand p62 for the Lck SH2 domain mRNA + 2124.Zyxin</td><td><div align=right>0.005</div></td></tr>
<tr><td>1417.Phosphotyrosine independent ligand p62 for the Lck SH2 domain mRNA + 2559.P4HB Procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), beta polypeptide (protein disulfide isomerase; thyroid hormone binding protein p55)</td><td><div align=right>0.005</div></td></tr>
<tr><td>1417.Phosphotyrosine independent ligand p62 for the Lck SH2 domain mRNA + 849.Oncoprotein 18 (Op18) gene + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1445.Protein kinase ATR mRNA + 848.PTX3 Pentaxin-related gene, rapidly induced by IL-1 beta</td><td><div align=right>0.005</div></td></tr>
<tr><td>1448.Leukotriene C4 synthase (LTC4S) gene + 2670.ELA2 Elastatse 2, neutrophil + 479.PROTEIN PHOSPHATASE PP2A, 65 KD REGULATORY SUBUNIT, ALPHA ISOFORM</td><td><div align=right>0.005</div></td></tr>
<tr><td>1455.PKD2 Autosomal dominant polycystic kidney disease type II + 2459.CD24 signal transducer mRNA and 3' region</td><td><div align=right>0.005</div></td></tr>
<tr><td>1455.PKD2 Autosomal dominant polycystic kidney disease type II + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1524.Putative enterocyte differentiation promoting factor mRNA, partial cds + 2418.Transcriptional activator hSNF2b + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1556.Lysophospholipase homolog (HU-K5) mRNA + 1920.SON SON DNA binding protein + 1978.OZF mRNA</td><td><div align=right>0.005</div></td></tr>
<tr><td>1676.Myeloid progenitor inhibitory factor-1 MPIF-1 mRNA + 849.Oncoprotein 18 (Op18) gene</td><td><div align=right>0.005</div></td></tr>
<tr><td>1778.PLECKSTRIN + 2438.CALM1 Calmodulin 1 (phosphorylase kinase, delta)</td><td><div align=right>0.005</div></td></tr>
<tr><td>1811.ALDR1 Aldehyde reductase 1 (low Km aldose reductase) + 849.Oncoprotein 18 (Op18) gene</td><td><div align=right>0.005</div></td></tr>
<tr><td>1811.ALDR1 Aldehyde reductase 1 (low Km aldose reductase) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1834.VIL2 Villin 2 (ezrin) + 394.Macmarcks + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1834.VIL2 Villin 2 (ezrin) + 792.ANPEP Alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1883.PROTEASOME IOTA CHAIN + 546.Protein tyrosine kinase related mRNA sequence</td><td><div align=right>0.005</div></td></tr>
<tr><td>1907.GRN Granulin + 2124.Zyxin + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage)</td><td><div align=right>0.005</div></td></tr>
<tr><td>1907.GRN Granulin + 2670.ELA2 Elastatse 2, neutrophil</td><td><div align=right>0.005</div></td></tr>
<tr><td>1907.GRN Granulin + 546.Protein tyrosine kinase related mRNA sequence + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1907.GRN Granulin + 606.High mobility group protein (HMG-I(Y)) gene exons 1-8</td><td><div align=right>0.005</div></td></tr>
<tr><td>1907.GRN Granulin + 849.Oncoprotein 18 (Op18) gene</td><td><div align=right>0.005</div></td></tr>
<tr><td>1911.ME491  gene extracted from H.sapiens gene for Me491/CD63 antigen + 350.KIAA0246 gene, partial cds</td><td><div align=right>0.005</div></td></tr>
<tr><td>1920.SON SON DNA binding protein + 2124.Zyxin</td><td><div align=right>0.005</div></td></tr>
<tr><td>1920.SON SON DNA binding protein + 2813.Epb72 gene exon 1</td><td><div align=right>0.005</div></td></tr>
<tr><td>1939.LMP2 gene extracted from H.sapiens genes TAP1, TAP2, LMP2, LMP7 and DOB + 2939.TCF3 Transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)</td><td><div align=right>0.005</div></td></tr>
<tr><td>1973.ERCC5 DNA excision repair protein ERCC5 + 2761.CD36 CD36 antigen (collagen type I receptor, thrombospondin receptor) + 546.Protein tyrosine kinase related mRNA sequence</td><td><div align=right>0.005</div></td></tr>
<tr><td>1977.CHRNA7 Cholinergic receptor, nicotinic, alpha polypeptide 7 + 2124.Zyxin</td><td><div align=right>0.005</div></td></tr>
<tr><td>1977.CHRNA7 Cholinergic receptor, nicotinic, alpha polypeptide 7 + 2289.MCM3 Minichromosome maintenance deficient (S. cerevisiae) 3</td><td><div align=right>0.005</div></td></tr>
<tr><td>1977.CHRNA7 Cholinergic receptor, nicotinic, alpha polypeptide 7 + 894.PPBP Connective tissue activation peptide III</td><td><div align=right>0.005</div></td></tr>
<tr><td>1995.RETINOBLASTOMA BINDING PROTEIN P48 + 283.KIAA0181 gene, partial cds + 523.SPTAN1 Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) + 894.PPBP Connective tissue activation peptide III</td><td><div align=right>0.005</div></td></tr>
<tr><td>1995.RETINOBLASTOMA BINDING PROTEIN P48 + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>1995.RETINOBLASTOMA BINDING PROTEIN P48 + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>2002.T-COMPLEX PROTEIN 1, GAMMA SUBUNIT + 2124.Zyxin + 2386.TOP2B Topoisomerase (DNA) II beta (180kD)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2002.T-COMPLEX PROTEIN 1, GAMMA SUBUNIT + 2198.LEPR Leptin receptor + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2002.T-COMPLEX PROTEIN 1, GAMMA SUBUNIT + 283.KIAA0181 gene, partial cds + 894.PPBP Connective tissue activation peptide III</td><td><div align=right>0.005</div></td></tr>
<tr><td>2002.T-COMPLEX PROTEIN 1, GAMMA SUBUNIT + 786.Neuromedin B mRNA</td><td><div align=right>0.005</div></td></tr>
<tr><td>2002.T-COMPLEX PROTEIN 1, GAMMA SUBUNIT + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>2122.Novel T-cell activation protein + 766.LYN V-yes-1 Yamaguchi sarcoma viral related oncogene homolog</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 2289.MCM3 Minichromosome maintenance deficient (S. cerevisiae) 3</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 2761.CD36 CD36 antigen (collagen type I receptor, thrombospondin receptor)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 2801.DHPS Deoxyhypusine synthase + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 2803.TFIIB related factor hBRF (HBRF) mRNA + 937.CTSD Cathepsin D (lysosomal aspartyl protease)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 283.KIAA0181 gene, partial cds</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 2870.HOX 2.2 gene extracted from Human Hox2.2 gene for a homeobox protein</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 2921.LYZ Lysozyme + 2922.Lysozyme gene (EC 3.2.1.17) + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 2939.TCF3 Transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 3046.Transcriptional activator hSNF2b</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 515.SNRPN Small nuclear ribonucleoprotein polypeptide N</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 566.INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL1</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 648.HnRNP F protein mRNA</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 703.RB1 Retinoblastoma 1 (including osteosarcoma)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 766.LYN V-yes-1 Yamaguchi sarcoma viral related oncogene homolog + 786.Neuromedin B mRNA</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 792.ANPEP Alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase M, microsomal aminopeptidase, CD13)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 849.Oncoprotein 18 (Op18) gene</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 849.Oncoprotein 18 (Op18) gene + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>2124.Zyxin + 894.PPBP Connective tissue activation peptide III</td><td><div align=right>0.005</div></td></tr>
<tr><td>2244.Phosphatidylinositol 3-kinase + 2939.TCF3 Transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2289.MCM3 Minichromosome maintenance deficient (S. cerevisiae) 3 + 2499.Epican, Alt. Splice 11 + 2702.MYL1 Myosin light chain (alkali) + 378.CYSTATIN A + 766.LYN V-yes-1 Yamaguchi sarcoma viral related oncogene homolog + 786.Neuromedin B mRNA</td><td><div align=right>0.005</div></td></tr>
<tr><td>2289.MCM3 Minichromosome maintenance deficient (S. cerevisiae) 3 + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2386.TOP2B Topoisomerase (DNA) II beta (180kD) + 2600.APLP2 Amyloid beta (A4) precursor-like protein 2</td><td><div align=right>0.005</div></td></tr>
<tr><td>2386.TOP2B Topoisomerase (DNA) II beta (180kD) + 2734.GLUL Glutamate-ammonia ligase (glutamine synthase)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2386.TOP2B Topoisomerase (DNA) II beta (180kD) + 523.SPTAN1 Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2386.TOP2B Topoisomerase (DNA) II beta (180kD) + 703.RB1 Retinoblastoma 1 (including osteosarcoma)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2386.TOP2B Topoisomerase (DNA) II beta (180kD) + 838.Translational initiation factor 2 beta subunit (elF-2-beta) mRNA</td><td><div align=right>0.005</div></td></tr>
<tr><td>2438.CALM1 Calmodulin 1 (phosphorylase kinase, delta) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>2499.Epican, Alt. Splice 11 + 786.Neuromedin B mRNA</td><td><div align=right>0.005</div></td></tr>
<tr><td>2600.APLP2 Amyloid beta (A4) precursor-like protein 2 + 96.KIAA0102 gene</td><td><div align=right>0.005</div></td></tr>
<tr><td>2670.ELA2 Elastatse 2, neutrophil + 2829.MEF2A gene (myocyte-specific enhancer factor 2A, C9 form) extracted from Human myocyte-specific enhancer factor 2A (MEF2A) gene, first coding</td><td><div align=right>0.005</div></td></tr>
<tr><td>2670.ELA2 Elastatse 2, neutrophil + 2939.TCF3 Transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2671.GB DEF = Neutrophil elastase gene, exon 5 + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2702.MYL1 Myosin light chain (alkali) + 378.CYSTATIN A</td><td><div align=right>0.005</div></td></tr>
<tr><td>2750.PFC Properdin P factor, complement + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage)</td><td><div align=right>0.005</div></td></tr>
<tr><td>283.KIAA0181 gene, partial cds + 422.Heat Shock Protein, 70 Kda (Gb:Y00371)</td><td><div align=right>0.005</div></td></tr>
<tr><td>283.KIAA0181 gene, partial cds + 896.FAH Fumarylacetoacetate + 937.CTSD Cathepsin D (lysosomal aspartyl protease)</td><td><div align=right>0.005</div></td></tr>
<tr><td>2860.Butyrophilin (BTF5) mRNA + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>2939.TCF3 Transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) + 378.CYSTATIN A + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>2939.TCF3 Transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) + 937.CTSD Cathepsin D (lysosomal aspartyl protease)</td><td><div align=right>0.005</div></td></tr>
<tr><td>304.KIAA0191 gene, partial cds + 848.PTX3 Pentaxin-related gene, rapidly induced by IL-1 beta</td><td><div align=right>0.005</div></td></tr>
<tr><td>378.CYSTATIN A + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage)</td><td><div align=right>0.005</div></td></tr>
<tr><td>378.CYSTATIN A + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>394.Macmarcks + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>515.SNRPN Small nuclear ribonucleoprotein polypeptide N + 738.Terminal transferase mRNA</td><td><div align=right>0.005</div></td></tr>
<tr><td>546.Protein tyrosine kinase related mRNA sequence + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>546.Protein tyrosine kinase related mRNA sequence + 937.CTSD Cathepsin D (lysosomal aspartyl protease)</td><td><div align=right>0.005</div></td></tr>
<tr><td>703.RB1 Retinoblastoma 1 (including osteosarcoma) + 849.Oncoprotein 18 (Op18) gene</td><td><div align=right>0.005</div></td></tr>
<tr><td>717.Inducible protein mRNA + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>750.UROD Uroporphyrinogen decarboxylase + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>766.LYN V-yes-1 Yamaguchi sarcoma viral related oncogene homolog + 808.CD33 CD33 antigen (differentiation antigen) + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>786.Neuromedin B mRNA + 829.CST3 Cystatin C (amyloid angiopathy and cerebral hemorrhage)</td><td><div align=right>0.005</div></td></tr>
<tr><td>803.PPGB Protective protein for beta-galactosidase (galactosialidosis) + 937.CTSD Cathepsin D (lysosomal aspartyl protease)</td><td><div align=right>0.005</div></td></tr>
<tr><td>808.CD33 CD33 antigen (differentiation antigen) + 848.PTX3 Pentaxin-related gene, rapidly induced by IL-1 beta</td><td><div align=right>0.005</div></td></tr>
<tr><td>848.PTX3 Pentaxin-related gene, rapidly induced by IL-1 beta + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
<tr><td>849.Oncoprotein 18 (Op18) gene + 896.FAH Fumarylacetoacetate</td><td><div align=right>0.005</div></td></tr>
</TABLE>
